Navigation Links
LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
Date:1/8/2014

LOS ANGELES (Jan. 8, 2014) While daily antibiotic use is the most effective method for preventing recurrent urinary tract infections in women, daily cranberry pills, daily estrogen therapy and monthly acupuncture treatments also have benefits that may be preferable for some patients, according to a new study by researchers at the Los Angeles Biomedical Research Institute (LA BioMed).

The study, published in the Jan. 15 issue of the journal, Clinical Infectious Diseases, said more than half of women suffer from a urinary tract infection at some time in their lives, often requiring antibiotics or other treatments to recover from the infections.

A smaller group of women will have three or more urinary tract infections per year and may require a more pro-active course of treatment to prevent these recurrent infections. The LA BioMed study is the first to use a modeling approach to compare the effectiveness of all of the most commonly used prophylactic measures.

"We described the benefit of each common management option so that women can find an approach to recurrent urinary tract infections that fits their needs," said Loren G. Miller, MD, MPH, LA BioMed infectious disease specialist and lead researcher for the study. "Daily antibiotic usage is the most beneficial by far in preventing recurrent urinary tract infections, but there are benefits to other forms of treatment as well for women who don't want to take antibiotics."

Urinary tract infections cause pain and often require women to miss work or school. They result in more than 6 million outpatient visits and 479,000 hospitalizations per year. The cost to society is estimated to be more than $2.47 billion annually.

The LA BioMed study compared the findings from previous studies and found that daily antibiotic usage reduced the urinary tract infection recurrence rate to 0.4 per year. Acupuncture therapy reduced the recurrence rate to 0.7 per year, but the study data is somewhat limited. Cranberry pills and estrogen therapy reduced the recurrence rate to 1.1 per year. Another approach is self-diagnosis and treatment of urinary tract infections, which, while not reducing recurrence rates, was associated with the highest quality of life of all management strategies.

All of these approaches saved money for insurance providers. All of these approaches except for self-diagnosis and treatment added to patients' out-of-pocket costs, from a mean of $140 per year for antibiotics to a mean of $946 a year for acupuncture. The researchers noted that patients usually bore most or all the cost of acupuncture, while health insurance often covered all or part of the cost of antibiotics.

"This study provides comparisons of prevention approaches so women can knowledgeably discuss with their providers the most appropriate way for them to manage recurrent urinary tract infections," said Dr. Miller. "Because patient preferences are very diverse, we laid out the benefits and costs of each approach to help the patient and provider choose an approach that best suits the patient's lifestyle and preferences."


'/>"/>

Contact: Laura Mecoy
lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Related medicine news :

1. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
2. Biomedical researchers receive Hartwell Foundation awards
3. LA BioMed receives Grand Challenges Explorations grant
4. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
5. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
6. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
7. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
8. LA BioMed investigators, Drs. Kevin Bruhn and Noah Craft, develop novel treatment for melanoma
9. LA BioMed investigator Dr. Christina Wang spearheads study on new male contraceptive gel
10. Louisiana Tech biomedical engineering professor earns recognition, funding for research
11. LA BioMed offers unique educational and research opportunity to local high school seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Fremont, California (PRWEB) , ... ... ... the leading provider of Microsoft secure remote access connectivity solutions, today announced ... deployed platform for Microsoft DirectAccess. The new Celestix SecureAccess release will enable ...
(Date:5/3/2016)... ... , ... Hydra Skin Sciences, a top-rated skincare company based in ... anti-aging skin care product that integrates Snow Algae Powder and six powerful ... thousand units worldwide within the first two months of release. , “We set out ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... helps healthcare organizations, especially medium and small physician practices, to better grasp and ... unique step-by-step approach that guides practices on a well-defined, expert-created path to compliance. ...
(Date:5/3/2016)... , ... May 03, 2016 ... ... Cruise Lines premiered the state-of-the-art Carnival Vista – the line’s largest cruise ... The Cruise Web has created an infographic spotlighting the Carnival Vista ...
(Date:5/2/2016)... ... May 03, 2016 , ... ... FDA approved sSOIP telemedicine stethoscope software that enables the stethoscope stream to go ... PCP-SSP and works with RNK’s flagship PCP-USB stethoscope. , Remote auscultation involves two ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016  ValGenesis, ... Lifecycle Management Solutions (VLMS) today announced that ... services for sufferers of chronic kidney failure ... to manage their corporate validation process. The ... a software solution to manage their validation ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
Breaking Medicine Technology: